It was found [118] that the expression of both STIM1 and ORAI1 correlated negatively with the Gleason score (the commonly used histopathological assessment of prostate cancer progression) and was lower in prostate carcinomas relative to the normal tissue. This evidence concerns the gene STIM1 and prostate cancer.